NOUVEAUX COMPOSES CAPABLES D'AVOIR UN EFFET ANTAGONISTE SUR LES LESIONS DES CELLULES BETA INDUITES PAR LE POLYPEPTIDE D'ACIDES AMINES (IAPP) ET L'INTOLERANCE AU GLUCOSE
Described are molecules specifically binding to human islet amyloid polypeptide (hIAPP) also known as amylin, particularly human-derived antibodies as well as fragments, derivatives and variants thereof for antagonizing islet amyloid polypeptide (IAPP) induced ß-cell damage and impaired glucose tolerance which are symptoms typically associated with diabetes mellitus type 2 (T2D).